Tevogen Inc.
TVGN
$7.34
$0.010.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -13.29% | -68.36% | -54.77% | -7.29% | -38.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.00% | -47.85% | -50.76% | -5.85% | -36.68% |
| Operating Income | -4.00% | 47.85% | 50.76% | 5.85% | 36.68% |
| Income Before Tax | -4.69% | 47.47% | 50.47% | 2.67% | 43.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.69% | 47.47% | 50.47% | 2.67% | 43.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.69% | 47.47% | 50.47% | 2.67% | 43.04% |
| EBIT | -4.00% | 47.85% | 50.76% | 5.85% | 36.68% |
| EBITDA | -5.21% | 47.94% | 51.17% | 5.23% | 37.45% |
| EPS Basic | 10.97% | 50.45% | 46.81% | 13.88% | 13.06% |
| Normalized Basic EPS | 9.98% | 51.36% | 48.55% | 15.51% | 46.67% |
| EPS Diluted | 10.97% | 50.45% | 46.81% | 13.88% | 14.35% |
| Normalized Diluted EPS | 9.98% | 51.36% | 48.55% | 15.51% | 46.67% |
| Average Basic Shares Outstanding | 16.29% | 8.00% | -3.74% | 15.19% | 6.80% |
| Average Diluted Shares Outstanding | 16.29% | 8.00% | -3.74% | 15.19% | 6.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |